Australian Clinical Labs Ltd (AU:ACL) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Australian Clinical Labs Ltd has announced a daily update on its ongoing on-market buy-back program, with a total of 1,205,864 shares bought back prior to the latest day and an additional 33,391 shares bought back on the previous day. This strategic move is part of the company’s efforts to enhance shareholder value and optimize capital structure.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.